Endava plc (NYSE:DAVA) Stake Cut by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lessened its holdings in Endava plc (NYSE:DAVA - Free Report) by 7.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 179,500 shares of the company's stock after selling 14,500 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.32% of Endava worth $12,059,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. Quadrant Capital Group LLC boosted its position in Endava by 100.0% during the 4th quarter. Quadrant Capital Group LLC now owns 324 shares of the company's stock valued at $25,000 after purchasing an additional 162 shares during the period. Tower Research Capital LLC TRC grew its position in shares of Endava by 433.3% during the third quarter. Tower Research Capital LLC TRC now owns 480 shares of the company's stock worth $39,000 after acquiring an additional 390 shares during the last quarter. Quantbot Technologies LP acquired a new stake in shares of Endava in the 1st quarter worth about $88,000. Bessemer Group Inc. bought a new stake in Endava in the 4th quarter valued at about $106,000. Finally, Hills Bank & Trust Co acquired a new position in Endava during the 1st quarter valued at about $142,000. Institutional investors own 56.90% of the company's stock.

Several research firms recently commented on DAVA. Deutsche Bank Aktiengesellschaft lowered their target price on Endava from $78.00 to $53.00 in a research report on Wednesday, May 24th. Morgan Stanley reissued an "overweight" rating and set a $70.00 target price on shares of Endava in a research note on Monday, July 24th. TheStreet lowered shares of Endava from a "b-" rating to a "c+" rating in a research note on Tuesday, April 25th. Citigroup lowered their price objective on shares of Endava from $95.00 to $85.00 in a research note on Monday, May 1st. Finally, Susquehanna dropped their target price on Endava from $104.00 to $100.00 in a report on Monday, June 12th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, Endava presently has a consensus rating of "Moderate Buy" and an average target price of $85.78.

NYSE DAVA opened at $51.32 on Wednesday. The company has a market capitalization of $2.91 billion, a PE ratio of 24.91 and a beta of 1.16. Endava plc has a 1-year low of $44.62 and a 1-year high of $115.86. The firm's fifty day simple moving average is $51.90 and its 200-day simple moving average is $63.93.

Endava (NYSE:DAVA - Get Free Report) last announced its quarterly earnings results on Tuesday, May 23rd. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.05. The business had revenue of $247.28 million during the quarter, compared to analyst estimates of $233.78 million. Endava had a return on equity of 19.77% and a net margin of 12.53%. As a group, analysts predict that Endava plc will post 1.76 EPS for the current year.

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in Europe, Latin America, North America, and internationally. It offers technology and digital advisory services for payments and financial services, and TMT sectors; IT strategies; business analysis services; program management services; digital product strategy services; and architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Endava, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.

While Endava currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.